首页> 美国卫生研究院文献>Bioengineered >The pilot-scale preparation of the SA-hGM-CSF bi-functional fusion protein
【2h】

The pilot-scale preparation of the SA-hGM-CSF bi-functional fusion protein

机译:SA-hGM-CSF双功能融合蛋白的中试规模制备

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The granulocyte-macrophage colony-stimulating factor (GM-CSF) can be used to induce a powerful immune response. Based on the specific binding of biotin and streptavidin, SA-hGM-CSF was anchored on the surface of biotinylated tumor cells, which could enhance the anti-tumor effect of tumor cell vaccines in our previous reports, suggesting it would have potential clinical value. Preparation of the biologically active proteins in large-scale production is the basis of clinical application, however, only a small amount of biologically active protein was obtained according to previous studies. In this study, we researched the effects of various factors on the purification and simultaneous renaturation of SA-hGM-CSF fusion protein by single factor experiment and orthogonal experiment. Here, we developed a viable pilot-scale trial in the fermentation, purification, refolding and freeze-drying of SA-hGM-CSF proteins in order to efficiently obtain more biologically active proteins with high purity, which will lay the foundation for industrial production.
机译:粒细胞巨噬细胞集落刺激因子(GM-CSF)可用于诱导强大的免疫反应。基于生物素和链霉亲和素的特异性结合,SA-hGM-CSF被锚定在生物素化的肿瘤细胞表面,这可以增强我们先前报告中肿瘤细胞疫苗的抗肿瘤作用,表明其具有潜在的临床价值。大规模生产生物活性蛋白的制备是临床应用的基础,但是,根据先前的研究,仅获得了少量的生物活性蛋白。在这项研究中,我们通过单因素实验和正交实验研究了各种因素对SA-hGM-CSF融合蛋白的纯化和同时复性的影响。在这里,我们开发了一个可行的中试试验,用于SA-hGM-CSF蛋白的发酵,纯化,重折叠和冷冻干燥,以有效地获得更多具有高纯度的生物活性蛋白,这将为工业生产奠定基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号